Verrica Pharmaceuticals (VRCA) Short term Debt (2017 - 2025)
Verrica Pharmaceuticals (VRCA) posted quarterly Short term Debt of $12.5 million for Q3 2025, down 1.7% quarter-over-quarter from $12.7 million in Q2 2025.
Verrica Pharmaceuticals (VRCA) Short term Debt (2017 - 2025) Analysis & Trends
Verrica Pharmaceuticals' Short term Debt history runs 8 years deep, the most recent figure standing at $12.5 million for Q3 2025.
- In Q3 2025, Short term Debt changed N/A year-over-year to $12.5 million; the TTM figure through Sep 2025 stood at $12.5 million (changed N/A YoY), while the FY2024 annual figure was $12.9 million, changed N/A from the prior year.
- Short term Debt for Q3 2025 stood at $12.5 million, down from $12.7 million in the prior quarter.
- The five-year high for Short term Debt was $42.3 million in Q2 2022, with the low at $12.5 million in Q3 2025.
- The 4-year median for Short term Debt is $40.8 million (2021), against an average of $30.0 million.
- The sharpest annual moves came in 2021 and 2022: Short term Debt advanced 18.2% in 2021, then gained 3.14% in 2022.
- Verrica Pharmaceuticals' Short term Debt stood at $41.7 million in 2021, then gained by 1.44% to $42.3 million in 2022, then plunged by 69.41% to $12.9 million in 2024, then slipped by 3.71% to $12.5 million in 2025.
- Business Quant data shows VRCA's Short term Debt at $12.5 million in Q3 2025, $12.7 million in Q2 2025, and $12.8 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Verrica Pharmaceuticals | 104.71 Mn | 93.51 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 12.46 Mn |
| Jun 30, 2025 | 12.67 Mn |
| Mar 31, 2025 | 12.82 Mn |
| Dec 31, 2024 | 12.94 Mn |
| Jun 30, 2022 | 42.29 Mn |
| Mar 31, 2022 | 42.00 Mn |
| Dec 31, 2021 | 41.69 Mn |
| Sep 30, 2021 | 41.35 Mn |
| Jun 30, 2021 | 41.01 Mn |
| Mar 31, 2021 | 40.67 Mn |
| Dec 31, 2020 | 35.32 Mn |
| Sep 30, 2020 | 34.98 Mn |
| Jun 30, 2020 | 34.72 Mn |
| Jun 30, 2019 | 6,000.00 |
| Dec 31, 2018 | 38,000.00 |
| Sep 30, 2018 | 38,000.00 |
| Jun 30, 2018 | 36,000.00 |
| Dec 31, 2017 | 14,000.00 |